Trending News
News
News
$1.5 Million Cleveland Foundation Grant Continues to Build Proteomics Infrastructure at Case Western Reserve University
The funding will allow the university to develop customized technologies and research to make a significant impact on human health.
News
Cytori and GE Healthcare Form Partnership to Commercialize StemSource in the U.S
GE Healthcare to commercialize Cytori’s StemSource® technology in the North American stem cell banking and research markets.
News
Ancora Co-Founder Louis Schofield Receives $100,000 Grant from Gates Foundation
The collaboration accelerates Dr. Schofield and the Ancora team’s effort to create cost-effective malaria vaccines utilizing carbohydrate synthesis.
News
Covidien Announces Definitive Agreement to Acquire VNUS Medical Technologies
The acquisition of a developer of medical devices for minimally invasive treatment of venous reflux disease expands Covidien’s its presence in the vascular market.
News
Eurogentec Launches new Oligo Synthesis Facility
Key facility expands Eurogentec’s global business in the life science research, molecular diagnostic, and clinical laboratory markets.
News
Exelixis and Boehringer Ingelheim Enter into Collaboration for Development of S1P1 Receptor Agonists
Companies establish an exclusive, worldwide collaboration with the aim to discover, develop and commercialize autoimmune disease therapies.
News
Cellexus and Groton Collaborate on Use of Automated Sampling with Single-Use Bioreactors
Collaboration uses Groton’s automated sampler with the Cellexus single-use bioreactors for aseptic sample extraction from cell culture.
News
Evotec Acquires Zebrafish Screening Operations of Summit Corporation
The acquisition against £ 0.5 million cash in 2009 expected to add approximately £ 1.5 million revenues in 2010.
News
Evotec to Re-engineer Drug Discovery and Development Operations
Evotec to concentrate all proprietary core research programs at its European operations.
News
Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
Both the companies gain right to exclusively license and/or sublicense a number of albumin fusion proteins in exchange for royalties and other consideration.
Advertisement